Page last updated: 2024-08-26

uftoral and epirubicin

uftoral has been researched along with epirubicin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kawabata, Y; Nio, Y; Ohishi, T; Sumi, S; Tamura, K; Yano, S	1
Fujimura, Y; Miyayama, H; Nagao, K; Nakagawa, K; Nishimura, R; Okazaki, S	1
Byun, JH; Choi, MG; Chung, IS; Hong, YS; Kang, JH; Kim, KW; Lee, KS; Lee, MA; Moon, DH; Park, SY; Shim, BY; Woo, IS	1

Trials

1 trial(s) available for uftoral and epirubicin

Article	Year
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Combinations; Epirubicin; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil	2005

Article

Year

A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.

Japanese journal of clinical oncology, 2005, Volume: 35, Issue:1

Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Combinations; Epirubicin; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil

2005

Other Studies

2 other study(ies) available for uftoral and epirubicin

Article	Year
[A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Duodenum; Epirubicin; Female; Fluorouracil; Gallbladder Neoplasms; Hepatectomy; Humans; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Pancreatectomy; Tegafur; Uracil	1999
[A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Combinations; Epirubicin; Female; Humans; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Receptor, ErbB-2; Taxoids; Tegafur; Trastuzumab; Uracil	2003

Article

Year

[A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3

Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Duodenum; Epirubicin; Female; Fluorouracil; Gallbladder Neoplasms; Hepatectomy; Humans; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Pancreatectomy; Tegafur; Uracil

1999

[A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab].

Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:6

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Combinations; Epirubicin; Female; Humans; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Receptor, ErbB-2; Taxoids; Tegafur; Trastuzumab; Uracil

2003